MiMedx Group (NASDAQ: MDXG) reported Q1 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $59 million versus the consensus estimate of $69.18 million.

GUIDANCE:

MiMedx Group sees FY2026 revenue of $260-290 million, versus the consensus of $314.4 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.